Melody Swartz and Jeffrey Hubbell of the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, will explore the use of a robust and inexpensive nanotechnology, which may penetrate lymph tissue to more effectively trigger immune responses, as a new tool for prevention of TB.
Grant ID
OPP53283
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False